Viking Therapeutics: Still On Track

Core Insights - Viking Therapeutics, Inc. (NASDAQ: VKTX) presents a significant investment opportunity, drawing parallels to the successful trajectory of Eli Lilly and Company [1] Company Analysis - The company is perceived as deeply undervalued with long-term potential that is often overlooked by the market [1] Industry Context - The analysis is informed by extensive experience in investment management since 1999, providing insights across various market cycles [1]